Naftidrofuryl in Chronic Arterial Disease Results of a Six Month Controlled Multicenter Study Using Naftidrofuryl Tablets 200 mg
- A focus on risk factor management. Belch, Jill J. F.; Creager, Mark A. // Vascular Medicine;2004, Vol. 9 Issue 3, p169
This article reports that peripheral arterial disease (PAD) and its most common manifestation, intermittent claudication (IC), are associated with considerable morbidity and mortality. The patient with PAD has well-documented risk factors for atherosclerosis. Because of these, combined with the...
- THE NATURAL COURSE OF PERIPHERAL ARTERIOSCLEROSIS OBLITERANS EVALUATED BY FLOW MEASUREMENTS. Bollinger, A.; Simon, H. J.; Mahler, F. // Angiology;Jul/Aug1969, Vol. 20 Issue 7, p414
The development of collateral vessels after acute or subacute limb artery occlusions was evaluated by measurements of reactive hyperemia flow in the calf (venous occlusion plethysmography). The study included 68 patients, on whom a total of 107 measurements were performed. The duration of...
- ENTRAPMENT OF THE POPLITEAL ARTERY AND ITS MANAGEMENT. Husni, E. A.; Ryu, C. K. // Angiology;Jul/Aug1971, Vol. 22 Issue 7, p380
Examines the relationship between the popliteal artery and medial head of the gastroenemius muscle. Methods of popliteal artery management; Presentation of a case of a patient with popliteal artery entrapment syndrome; Alternative logical surgical approach for the treatment of the disease.
- Efficacy and Safety of Pentoxifylline in Geriatric Patients with Intermittent Claudication. Crowder, John E.; Cohn, Jay B.; Savitsky, J. Philip; Morgan, DeAnn L.; Slywka, Joseph; Cobert, Barton L.; Hryniewicki, Stephen W.; Piccirillo, Ronald T.; Wilcox, Charles S. // Angiology;Sep1989, Vol. 40 Issue 9, p795
The effects of pentoxifylline on intermittent claudication were evaluated at a dose of 1200 mg/day in an open-label twelve-week study on geriatric patients with chronic occlusive arterial disease (COAD). Standardized treadmill testing and clinical signs and symptoms of COAD were followed up...
- PERIPHERAL ARTERIAL DISEASE: STRATEGIES FOR TREATMENT. Dugdill, Shiela; Smout, Jonathan // Practice Nurse;9/10/2004, Vol. 28 Issue 4, p50
Presents strategies for reducing the risk of serious vascular attacks in patients with peripheral arterial disease (PAD). Presence of intermittent claudication; Signs and symptoms of PAD; Treatment.
- PERITRATE IN PERIPHERAL ARTERIAL DISEASES. Samuels, Saul S.; Padernacht, Elias D. // Angiology;Feb1952, Vol. 3 Issue 1, p20
Clinical study of 30 cases of arteriosclerosis obliterans treated with Peritrate showed improvement in symptoms of intermittent claudication in 20 cases. Final determination of the value of this, as well as all other vasodilators, must await extensive objective studies of a large series of cases...
- DISCUSSION. Sanchez, Luis A. // Vascular Surgery;Mar/Apr1997, Vol. 31 Issue 2, p161
Comments on a study by Phillip J. Bendick et al on the arterial adaptation to increased wall shear stress. Factor associated with the development of atherosclerotic plaques; Purpose of the technique used in non-atherogenic model.
- Complete atherosclerotic occlusion of infra-renal aorta and bilateral renal artery stenosis. Srivastava, Shalabh; Abeygunasekara, Sumith C. // NDT Plus;Aug2011 Supplement 4, Vol. 4 Issue 4, p273
No abstract available.
- Risk Factor Profile of Nonsmokers with Peripheral Arterial Disease. Fowkes, F. G. R.; Dunbar, J. T.; Lee, A. J. // Angiology;Aug1995, Vol. 46 Issue 8, p657
Cigarette smoking is a very common and important risk factor for peripheral arterial disease (PAD) such that a history of never having smoked is unusual in diseased subjects. The aim of this study was to determine whether never smokers with PAD had a unique risk factor profile that put them at...